Fidelity Select Biotechnology Portfolio (FBIOX)
24.77
+0.16
(+0.65%)
USD |
Mar 19 2026
FBIOX Asset Allocations & Exposures
Asset Allocation
As of January 31, 2026.
| Type | % Net |
|---|---|
| Cash | -0.04% |
| Stock | 99.48% |
| Bond | 0.03% |
| Convertible | 0.00% |
| Preferred | 0.47% |
| Other | 0.06% |
Market Capitalization
As of January 31, 2026
| Large | 36.09% |
| Mid | 10.35% |
| Small | 53.56% |
Region Exposure
| Americas | 84.24% |
|---|---|
|
North America
|
84.24% |
| Canada | 0.28% |
| United States | 83.95% |
|
Latin America
|
0.00% |
As of January 31, 2026. Region breakdown data is
calculated by using the long position holdings of the portfolio.
| Greater Europe | 13.78% |
|---|---|
| United Kingdom | 2.19% |
|
Europe Developed
|
11.59% |
| Belgium | 2.31% |
| Denmark | 3.41% |
| France | 0.99% |
| Germany | 0.18% |
| Ireland | 0.16% |
| Netherlands | 3.28% |
| Sweden | 0.09% |
| Switzerland | 1.16% |
|
Europe Emerging
|
0.00% |
|
Africa And Middle East
|
0.00% |
| Greater Asia | 0.24% |
|---|---|
| Japan | 0.00% |
|
Australasia
|
0.00% |
|
Asia Developed
|
0.24% |
| Singapore | 0.24% |
|
Asia Emerging
|
0.00% |
| Unidentified Region | 1.74% |
|---|
Stock Sector Exposure
| Cyclical |
|
0.00% |
| Materials |
|
0.00% |
| Consumer Discretionary |
|
0.00% |
| Financials |
|
0.00% |
| Real Estate |
|
0.00% |
| Sensitive |
|
0.00% |
| Communication Services |
|
0.00% |
| Energy |
|
0.00% |
| Industrials |
|
0.00% |
| Information Technology |
|
0.00% |
| Defensive |
|
98.16% |
| Consumer Staples |
|
0.00% |
| Health Care |
|
98.16% |
| Utilities |
|
0.00% |
| Not Classified |
|
1.84% |
| Non Classified Equity |
|
1.77% |
| Not Classified - Non Equity |
|
0.07% |
As of January 31, 2026
Stock Style Exposure
| Large Cap Value | -- |
| Large Cap Core | -- |
| Large Cap Growth | -- |
| Mid Cap Value | -- |
| Mid Cap Core | -- |
| Mid Cap Growth | -- |
| Small Cap Value | -- |
| Small Cap Core | -- |
| Small Cap Growth | -- |